S, N., K, S., T, K., H, K., A, F., S, T., . . . T, S. (2020). Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press.
Style de citation Chicago (17e éd.)S, Noguchi, Suminaga K, Kaki T, Kawachi H, Fukao A, Terashita S, Horikawa S, Ikeue T, et Sugita T. Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)S, Noguchi, et al. Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.